uninfected patient
Recently Published Documents


TOTAL DOCUMENTS

8
(FIVE YEARS 3)

H-INDEX

2
(FIVE YEARS 0)

2021 ◽  
Vol Volume 14 ◽  
pp. 2173-2177
Author(s):  
Wen Zeng ◽  
Ye Qiu ◽  
Mengxin Tang ◽  
Hui Zhang ◽  
Mianluan Pan ◽  
...  

2021 ◽  
Vol 107 ◽  
pp. 35-39
Author(s):  
J.S. Hinson ◽  
R.E. Rothman ◽  
K. Carroll ◽  
H.H. Mostafa ◽  
K. Ghobadi ◽  
...  

2012 ◽  
Vol 51 (13) ◽  
pp. 1793-1796 ◽  
Author(s):  
Jiun-Chi Huang ◽  
Mei-Chuan Kuo ◽  
Shang-Jyh Hwang ◽  
Daw-Yang Hwang ◽  
Hung-Chun Chen

1970 ◽  
Vol 19 (4) ◽  
pp. 3200-3207
Author(s):  
I Govender ◽  
O M Maphasha ◽  
S Rangiah ◽  
C Steyn

Introduction: Pneumocystis jirovecii is the causative organism of Pneumocystis pneumonia (PCP) in humans, which is more common among immunocompromised patients. Classically patients present with fever, non-productive cough, and dyspnoea. In the HIV-infected individuals the symptoms may be subtle at first, but gradually progress over several weeks. In the HIV-uninfected patient, however, the duration of symptoms is shorter and more severe, mainly due to the increased inflammatory response of the HIV-uninfected patient.Methods: This article focuses on the diagnostic methods and then the management and prophylaxis principles of PCP by reviewing the best current practices and guidelines in Africa.Conclusion: This overview is presented by clinicians who have experience with PCP and is directed mainly at first-line healthcare providers.Keywords: Pneumocystis jirovecii pneumonia, african generalist practitioner.


Sign in / Sign up

Export Citation Format

Share Document